Shares

22 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2023

Aug 14, 2023

SELL
$160.94 - $186.23 $4.15 Million - $4.81 Million
-25,808 Reduced 14.47%
152,498 $26.3 Million
Q1 2023

May 15, 2023

SELL
$145.48 - $175.02 $76.8 Million - $92.4 Million
-528,163 Reduced 74.76%
178,306 $29.7 Million
Q4 2022

Feb 14, 2023

SELL
$131.14 - $157.47 $40 Million - $48.1 Million
-305,345 Reduced 30.18%
706,469 $104 Million
Q3 2022

Nov 14, 2022

SELL
$148.29 - $182.55 $159 Million - $196 Million
-1,074,981 Reduced 51.51%
1,011,814 $150 Million
Q2 2022

Aug 15, 2022

SELL
$155.97 - $200.09 $193 Million - $248 Million
-1,239,653 Reduced 37.27%
2,086,795 $359 Million
Q1 2022

May 13, 2022

BUY
$181.39 - $234.03 $381 Million - $492 Million
2,102,306 Added 171.74%
3,326,448 $627 Million
Q4 2021

Feb 14, 2022

SELL
$193.69 - $247.03 $37.2 Million - $47.4 Million
-191,942 Reduced 13.55%
1,224,142 $299 Million
Q3 2021

Nov 12, 2021

BUY
$189.29 - $209.69 $94.4 Million - $105 Million
498,758 Added 54.37%
1,416,084 $275 Million
Q2 2021

Aug 13, 2021

SELL
$155.9 - $187.99 $38 Million - $45.9 Million
-244,019 Reduced 21.01%
917,326 $171 Million
Q1 2021

May 14, 2021

BUY
$144.0 - $169.39 $140 Million - $164 Million
968,926 Added 503.55%
1,161,345 $183 Million
Q4 2020

Feb 12, 2021

BUY
$157.07 - $174.35 $29.5 Million - $32.7 Million
187,690 Added 3968.92%
192,419 $31.8 Million
Q3 2020

Nov 12, 2020

SELL
$137.1 - $165.37 $10.6 Million - $12.8 Million
-77,114 Reduced 94.22%
4,729 $782,000
Q2 2020

Aug 12, 2020

SELL
$111.92 - $142.53 $28.1 Million - $35.8 Million
-251,186 Reduced 75.42%
81,843 $11.2 Million
Q1 2020

May 15, 2020

BUY
$92.66 - $144.94 $30.9 Million - $48.3 Million
333,029 New
333,029 $39.2 Million
Q2 2019

Aug 14, 2019

SELL
$97.98 - $114.28 $70.9 Million - $82.8 Million
-724,109 Closed
0 $0
Q1 2019

May 15, 2019

SELL
$81.56 - $100.67 $24.7 Million - $30.5 Million
-303,215 Reduced 29.52%
724,109 $72.9 Million
Q4 2018

Feb 14, 2019

BUY
$79.28 - $95.27 $8.81 Million - $10.6 Million
111,119 Added 12.13%
1,027,324 $87.9 Million
Q3 2018

Nov 14, 2018

BUY
$83.5 - $93.23 $49.4 Million - $55.1 Million
591,125 Added 181.84%
916,205 $83.9 Million
Q2 2018

Aug 14, 2018

BUY
$79.9 - $89.2 $24.8 Million - $27.7 Million
310,380 Added 2111.43%
325,080 $27.7 Million
Q1 2018

May 14, 2018

SELL
$71.51 - $84.69 $37.6 Million - $44.5 Million
-525,347 Reduced 97.28%
14,700 $1.23 Million
Q4 2017

Feb 09, 2018

BUY
$63.24 - $72.8 $23.7 Million - $27.3 Million
375,347 Added 227.9%
540,047 $38.9 Million
Q3 2017

Nov 14, 2017

BUY
$59.73 - $65.4 $9.84 Million - $10.8 Million
164,700
164,700 $10.5 Million

Others Institutions Holding ZTS

About Zoetis Inc.


  • Ticker ZTS
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 468,139,008
  • Market Cap $85.6B
  • Description
  • Zoetis Inc. discovers, develops, manufactures, and commercializes animal health medicines, vaccines, and diagnostic products in the United States and internationally. It commercializes products primarily across species, including livestock, such as cattle, swine, poultry, fish, and sheep; and companion animals comprising dogs, cats, and horses. ...
More about ZTS
Track This Portfolio

Track Arrowstreet Capital, Limited Partnership Portfolio

Follow Arrowstreet Capital, Limited Partnership and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Arrowstreet Capital, Limited Partnership, based on Form 13F filings with the SEC.

News

Stay updated on Arrowstreet Capital, Limited Partnership with notifications on news.